2026· Proceedings of the 4th International Conference on Image, Algorithms, and Artificial Intelligence, ICIAAI 2026, 22-24 May 2026, Singapore, Singapore· 0 citations· 4 references
TL;DR
The current application status of artificial intelligence in DDI prediction can promote existing pharmacological theories and provide practical references for clinical medication, which can promote existing pharmacological theories and provide practical references for clinical medication.
Abstract
. While drug combination therapy can enhance efficacy, it may also trigger drug interactions. Traditional detection methods are time-consuming and costly, making artificial intelligence an important auxiliary technology. This article reviews traditional machine learning methods and deep learning methods perspectives. Traditional machine learning methods can use the Drug – Drug Interaction (DDI) information database of pharmacokinetics (PK) for prediction, but this method has a relatively high bias risk for all models. Deep learning methods often establish models based on neural networks, and the results are relatively more accurate. Artificial intelligence has played an important role in DDI prediction, but there are still limitations such as insufficient consideration of clinical factors and inconsistent use of data sets, which are expected to be resolved. This article summarizes the current application status of artificial intelligence in DDI prediction, which can promote existing pharmacological theories and provide practical references for clinical medication.
This review systematically analyzes key challenges in DDI prediction: balancing model performance with interpretability, integrating heterogeneous features, ensuring sample set reliability, and optimizing algorithmic architectures, and outlines promising directions for future innovation.
Yun Zuo, Jia-Yi Ji, Yuwen Li et al.· Current Bioinformatics· 0 citations
Combination therapy is a common strategy in cancer treatment to improve efficacy, minimize side effects, and overcome drug resistance. However, the vast number of possible drug pairings makes experimental screening both time-consuming and costly. Drug interactions can result in synergy and antagonism, emphasizing the n...
Azar Shamloo, Jack Tuszynski, Yun Tam et al.· International Journal of Mol...· 0 citations
Two deep learning-based computational protocols designed to address drug mechanisms of action and predicting drug-target interactions are presented, offering scalable, cost-effective tools for accelerating therapeutic development by bridging chemical structure, molecular interactions, and systems-level biological respo...
Y. Sun, Cheng-You Liu, Zi-Hao Jing et al.· Methods in molecular biology· 0 citations
Type 2 diabetes (T2D) is a major global health challenge that requires continuous investigation
of alternative therapeutic strategies. Drug repurposing is a strategic technique that involves
identifying new therapeutic applications from existing drugs. This research developed a machine
learning framework that combine...
Johnson Opeyemi Olayinka· JOURNAL OF BIOLOGY AND GENET...· 0 citations
A paradigm shift toward autonomous scientific agents capable of causal reasoning and end-to-end experimental guidance is highlighted, and persistent challenges are discussed, including data bias, limited interpretability, and in silico-to-wet lab translation.
The many advantages of AI in drug development are highlighted in this paper, including increased accuracy, reduced risks, and increased efficiency, including increased accuracy, reduced risks, and increased efficiency.
{"name":"Shaik Sana","email":"shaiksana79313@gmail.com","affiliat, {"name":"Sarvepalli Revathi","email":"shaiksana79313@gmail.com","affil, {"name":"Yerikala Ramesh","email":"shaiksana79313@gmail.com","affili et al.· Future Journal of Pharmaceut...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.